Patients with deep scleritis typically present with severe eye pain that may radiate to the forehead, jaw, or sinuses. The pain is often described as a deep, boring sensation and can be exacerbated by eye movement. Redness of the eye, decreased vision, and sensitivity to light (photophobia) are common symptoms. Unlike anterior scleritis, the redness in deep scleritis may not be as apparent, making it more challenging to diagnose based on appearance alone.

Diagnosing deep scleritis involves a thorough clinical examination by an ophthalmologist. The workup may include:

• Slit-lamp examination: A detailed eye exam using a special microscope to assess the sclera and other eye structures.
• Ultrasound: An ocular ultrasound can help visualize the deeper layers of the sclera and confirm the diagnosis.
• Blood tests: These may be conducted to identify any underlying systemic conditions, such as autoimmune diseases, that could be contributing to the inflammation.
• Imaging: In some cases, imaging studies like MRI may be used to assess the extent of inflammation and rule out other conditions.

The treatment of deep scleritis focuses on reducing inflammation and managing pain. Options include:

• Nonsteroidal anti-inflammatory drugs (NSAIDs): These are often the first line of treatment for mild cases.
• Corticosteroids: Oral or injectable steroids may be necessary for more severe inflammation.
• Immunosuppressive agents: In cases associated with systemic autoimmune diseases, medications that suppress the immune system may be required.
• Biologic agents: These are newer treatments that target specific pathways in the immune system and may be used in refractory cases.

The prognosis for deep scleritis varies depending on the underlying cause and the timeliness of treatment. With appropriate management, many patients experience relief from symptoms and preservation of vision. However, if left untreated, deep scleritis can lead to complications such as scleral thinning, perforation, or vision loss.

Deep scleritis can be idiopathic, meaning its cause is unknown, or it can be associated with systemic diseases. Common systemic associations include rheumatoid arthritis, lupus, and other autoimmune conditions. Infections, trauma, or previous eye surgery can also be contributing factors.

Deep scleritis is a rare condition, with a lower incidence compared to anterior scleritis. It can occur at any age but is more common in adults. There is a slight female predominance, and it is often associated with systemic autoimmune diseases.

The pathophysiology of deep scleritis involves an inflammatory response in the sclera's deeper layers. This inflammation can be due to immune system dysregulation, where the body's immune system mistakenly attacks its own tissues. The resulting inflammation leads to the symptoms and potential complications associated with the condition.

Preventing deep scleritis involves managing any underlying systemic conditions effectively. Regular follow-ups with healthcare providers and adherence to prescribed treatments for autoimmune diseases can reduce the risk of developing scleritis. Early recognition and treatment of symptoms are crucial to prevent complications.

Deep scleritis is a serious inflammatory condition of the eye's sclera, often associated with systemic diseases. It presents with severe eye pain and can lead to vision complications if untreated. Diagnosis involves clinical examination and imaging, while treatment focuses on reducing inflammation and managing underlying conditions. Early intervention is key to a favorable outcome.

If you experience severe eye pain, redness, or vision changes, it is important to seek medical attention. Deep scleritis is a condition that requires prompt diagnosis and treatment to prevent complications. Managing any underlying health issues and following your doctor's advice can help maintain eye health and prevent future episodes.